Proteomic expression profiling of breast cancer

Hans Neubauer, Tanja Fehm, Christina Schütz, Runa Speer, Erich Solomayer, Andre Schrattenholz, Michael Cahill, Raffael Kurek

Research output: Book chapter/Published conference paperChapter

6 Citations (Scopus)

Abstract

Breast cancer is one of the most common cancers observed in women in industrialized Western countries. The development of novel diagnostic methods and the application of modern systemic therapies have significantly optimized early detection and therapy of breast cancer. However, many patients are currently overtreated. Traditionally, tumours have been categorized on the basis of histopathological criteria. However, staining pattern and intensity of cancer cells are not sufficient to reflect the molecular events driving tumour development and progression. Therefore, new genomic, transcriptomic and proteomic techniques are applied to clinical samples aiming to identify new targets for a therapy tailored for an individual patient. After an introduction to common genomic and transcriptomic profiling technologies and their relevance for clinical use, we will focus on analytical and preanalytical applications for the identification of new therapeutic targets by protein profiling, with a special emphasis on two-dimensional gel-technologies (2D-PAGE), particularly as they apply to the study of breast cancer.
Original languageEnglish
Title of host publicationTargeted Therapies in Cancer
EditorsManfred Dietel
Place of PublicationBerlin, Germany
PublisherSpringer
Pages89-120
Number of pages32
Volume176
Edition9
ISBN (Print)9783540460909
DOIs
Publication statusPublished - 2007

Fingerprint

Proteomics
Breast Neoplasms
Neoplasms
Technology
Electrophoresis, Gel, Two-Dimensional
Secondary Prevention
Developed Countries
Therapeutics
Gels
Staining and Labeling
Proteins

Cite this

Neubauer, H., Fehm, T., Schütz, C., Speer, R., Solomayer, E., Schrattenholz, A., ... Kurek, R. (2007). Proteomic expression profiling of breast cancer. In M. Dietel (Ed.), Targeted Therapies in Cancer (9 ed., Vol. 176, pp. 89-120). Berlin, Germany: Springer. https://doi.org/10.1007/978-3-540-46091-6_9
Neubauer, Hans ; Fehm, Tanja ; Schütz, Christina ; Speer, Runa ; Solomayer, Erich ; Schrattenholz, Andre ; Cahill, Michael ; Kurek, Raffael. / Proteomic expression profiling of breast cancer. Targeted Therapies in Cancer. editor / Manfred Dietel. Vol. 176 9. ed. Berlin, Germany : Springer, 2007. pp. 89-120
@inbook{0019db8159044cf0a8ad9f04c5274cf0,
title = "Proteomic expression profiling of breast cancer",
abstract = "Breast cancer is one of the most common cancers observed in women in industrialized Western countries. The development of novel diagnostic methods and the application of modern systemic therapies have significantly optimized early detection and therapy of breast cancer. However, many patients are currently overtreated. Traditionally, tumours have been categorized on the basis of histopathological criteria. However, staining pattern and intensity of cancer cells are not sufficient to reflect the molecular events driving tumour development and progression. Therefore, new genomic, transcriptomic and proteomic techniques are applied to clinical samples aiming to identify new targets for a therapy tailored for an individual patient. After an introduction to common genomic and transcriptomic profiling technologies and their relevance for clinical use, we will focus on analytical and preanalytical applications for the identification of new therapeutic targets by protein profiling, with a special emphasis on two-dimensional gel-technologies (2D-PAGE), particularly as they apply to the study of breast cancer.",
keywords = "(Neoplasm Proteins), Breast Neoplasms/*metabolism, Female, Genomics, Humans, Neoplasm Proteins/*analysis, Protein Array Analysis, Proteomics/*methods",
author = "Hans Neubauer and Tanja Fehm and Christina Sch{\"u}tz and Runa Speer and Erich Solomayer and Andre Schrattenholz and Michael Cahill and Raffael Kurek",
note = "Imported on 12 May 2017 - DigiTool details were: publisher = Berlin, Germany: Springer, 2007. editor/s (773b) = Manfred Dietel ; Volume no. (773r) = 176; Issue no. (773s) = 9; Parent title (773t) = Targeted Therapies in Cancer.",
year = "2007",
doi = "10.1007/978-3-540-46091-6_9",
language = "English",
isbn = "9783540460909",
volume = "176",
pages = "89--120",
editor = "Manfred Dietel",
booktitle = "Targeted Therapies in Cancer",
publisher = "Springer",
address = "United States",
edition = "9",

}

Neubauer, H, Fehm, T, Schütz, C, Speer, R, Solomayer, E, Schrattenholz, A, Cahill, M & Kurek, R 2007, Proteomic expression profiling of breast cancer. in M Dietel (ed.), Targeted Therapies in Cancer. 9 edn, vol. 176, Springer, Berlin, Germany, pp. 89-120. https://doi.org/10.1007/978-3-540-46091-6_9

Proteomic expression profiling of breast cancer. / Neubauer, Hans; Fehm, Tanja; Schütz, Christina; Speer, Runa; Solomayer, Erich; Schrattenholz, Andre; Cahill, Michael; Kurek, Raffael.

Targeted Therapies in Cancer. ed. / Manfred Dietel. Vol. 176 9. ed. Berlin, Germany : Springer, 2007. p. 89-120.

Research output: Book chapter/Published conference paperChapter

TY - CHAP

T1 - Proteomic expression profiling of breast cancer

AU - Neubauer, Hans

AU - Fehm, Tanja

AU - Schütz, Christina

AU - Speer, Runa

AU - Solomayer, Erich

AU - Schrattenholz, Andre

AU - Cahill, Michael

AU - Kurek, Raffael

N1 - Imported on 12 May 2017 - DigiTool details were: publisher = Berlin, Germany: Springer, 2007. editor/s (773b) = Manfred Dietel ; Volume no. (773r) = 176; Issue no. (773s) = 9; Parent title (773t) = Targeted Therapies in Cancer.

PY - 2007

Y1 - 2007

N2 - Breast cancer is one of the most common cancers observed in women in industrialized Western countries. The development of novel diagnostic methods and the application of modern systemic therapies have significantly optimized early detection and therapy of breast cancer. However, many patients are currently overtreated. Traditionally, tumours have been categorized on the basis of histopathological criteria. However, staining pattern and intensity of cancer cells are not sufficient to reflect the molecular events driving tumour development and progression. Therefore, new genomic, transcriptomic and proteomic techniques are applied to clinical samples aiming to identify new targets for a therapy tailored for an individual patient. After an introduction to common genomic and transcriptomic profiling technologies and their relevance for clinical use, we will focus on analytical and preanalytical applications for the identification of new therapeutic targets by protein profiling, with a special emphasis on two-dimensional gel-technologies (2D-PAGE), particularly as they apply to the study of breast cancer.

AB - Breast cancer is one of the most common cancers observed in women in industrialized Western countries. The development of novel diagnostic methods and the application of modern systemic therapies have significantly optimized early detection and therapy of breast cancer. However, many patients are currently overtreated. Traditionally, tumours have been categorized on the basis of histopathological criteria. However, staining pattern and intensity of cancer cells are not sufficient to reflect the molecular events driving tumour development and progression. Therefore, new genomic, transcriptomic and proteomic techniques are applied to clinical samples aiming to identify new targets for a therapy tailored for an individual patient. After an introduction to common genomic and transcriptomic profiling technologies and their relevance for clinical use, we will focus on analytical and preanalytical applications for the identification of new therapeutic targets by protein profiling, with a special emphasis on two-dimensional gel-technologies (2D-PAGE), particularly as they apply to the study of breast cancer.

KW - (Neoplasm Proteins)

KW - Breast Neoplasms/metabolism

KW - Female

KW - Genomics

KW - Humans

KW - Neoplasm Proteins/analysis

KW - Protein Array Analysis

KW - Proteomics/methods

U2 - 10.1007/978-3-540-46091-6_9

DO - 10.1007/978-3-540-46091-6_9

M3 - Chapter

SN - 9783540460909

VL - 176

SP - 89

EP - 120

BT - Targeted Therapies in Cancer

A2 - Dietel, Manfred

PB - Springer

CY - Berlin, Germany

ER -

Neubauer H, Fehm T, Schütz C, Speer R, Solomayer E, Schrattenholz A et al. Proteomic expression profiling of breast cancer. In Dietel M, editor, Targeted Therapies in Cancer. 9 ed. Vol. 176. Berlin, Germany: Springer. 2007. p. 89-120 https://doi.org/10.1007/978-3-540-46091-6_9